
Sign up to save your podcasts
Or


A national study of medical cannabis patients sponsored by Tilray, concludes that medical cannabis significantly reduces the use of prescription opioids and improves the quality of life. Graduate Researcher at Victoria University and VP Global Patient Research and Access at Tilray Phillippe Lucas discusses the study's findings.
By Jeff AndreasA national study of medical cannabis patients sponsored by Tilray, concludes that medical cannabis significantly reduces the use of prescription opioids and improves the quality of life. Graduate Researcher at Victoria University and VP Global Patient Research and Access at Tilray Phillippe Lucas discusses the study's findings.